Metformin may boost survival in ovarian cancer patients with diabetes

12/3/2012 | WebMD

Data on 239 ovarian cancer patients showed 67% of metformin-treated patients with comorbid diabetes did not die of cancer at five years, compared with 47% of nonusers without diabetes. The findings were published in the journal Cancer.

View Full Article in:

WebMD

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD